83 FR 20099 - Designation of Three High Intensity Drug Trafficking Areas

EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy

Federal Register Volume 83, Issue 88 (May 7, 2018)

Page Range20099-20099
FR Document2018-09567

The Director of the Office of National Drug Control Policy designated three areas as High Intensity Drug Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. These areas are the First, Third, and Fourth Judicial Districts of Alaska.

Federal Register, Volume 83 Issue 88 (Monday, May 7, 2018)
[Federal Register Volume 83, Number 88 (Monday, May 7, 2018)]
[Notices]
[Page 20099]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-09567]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Designation of Three High Intensity Drug Trafficking Areas

AGENCY: Office of National Drug Control Policy, Executive Office of the 
President.

ACTION: Notice of HIDTA designations.

-----------------------------------------------------------------------

SUMMARY: The Director of the Office of National Drug Control Policy 
designated three areas as High Intensity Drug Trafficking Areas (HIDTA) 
pursuant to 21 U.S.C. 1706. These areas are the First, Third, and 
Fourth Judicial Districts of Alaska.

FOR FURTHER INFORMATION CONTACT: Questions regarding this notice should 
be directed to Michael K. Gottlieb, National HIDTA Program Director, 
Office of National Drug Control Policy, Executive Office of the 
President, Washington, DC 20503; (202) 395-4868.

    Dated: May 1, 2018.
Michael J. Passante,
Acting General Counsel.
[FR Doc. 2018-09567 Filed 5-4-18; 8:45 am]
 BILLING CODE 3280-F5-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of HIDTA designations.
ContactQuestions regarding this notice should be directed to Michael K. Gottlieb, National HIDTA Program Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 395-4868.
FR Citation83 FR 20099 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR